Skip to Main Content

Author Details

Philippe Moingeon
France French Academy of Pharmacy
1983
185
50
PMIDPaper TitleJournal TitlePublished Year
36680799Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises.Expert Rev Clin Immunol2023
37268540Artificial intelligence-driven drug development against autoimmune diseases.Trends Pharmacol Sci2023
34842494Model-based computational precision medicine to develop combination therapies for autoimmune diseases.Expert Rev Clin Immunol2022
35786124Industrializing AI-powered drug discovery: lessons learned from the <i>Patrimony</i> computing platform.Expert Opin Drug Discov2022
35485890[Systemic lupus erythematosus: A new indication for CAR-T cell therapies?]Med Sci (Paris)2022
35179468[Sjögren's syndrome: Towards precision medicine].Med Sci (Paris)2022
34937491Proteomics in support of immunotherapy: contribution to model-based precision medicine.Expert Rev Proteomics2022
34555509Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine.Drug Discov Today2022
34224903IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases.Drug Discov Today2021
36474760Applications of transcriptomics in support of drug development for osteoarthritis.Osteoarthr Cartil Open2021
33529579[Applications of artificial intelligence to new drug development].Ann Pharm Fr2021
33748735S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases.J Transl Autoimmun2021
34663440A deep learning method for predicting knee osteoarthritis radiographic progression from MRI.Arthritis Res Ther2021
34293006Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.PLoS One2021
32908251Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.Nat Med2020
31774179State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI).Allergy2020
33247289Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.Nat Med2020
32807934A dynamic COVID-19 immune signature includes associations with poor prognosis.Nat Med2020
30475388CCR10<sup>+</sup> ILC2s with ILC1-like properties exhibit a protective function in severe allergic asthma.Allergy2019
30793324IL-10 mRNA levels in whole blood cells correlate with house dust mite allergen immunotherapy efficacy.Allergy2019
29171882Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.Allergy2018
28065340Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy.J Allergy Clin Immunol Pract2017
28497578Effector and regulatory dendritic cells display distinct patterns of miRNA expression.Immun Inflamm Dis2017
28122129Novel approaches and perspectives in allergen immunotherapy.Allergy2017
29025471Enhancing sublingual immunotherapy by systemic or local factors: A role for vitamin D and lingual tonsil?Allergy Asthma Proc2017
28982170A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species.PLoS One2017
29143737Validation of ELISA methods for quantification of the major birch allergen Bet v 1 (BSP090).Pharmeur Bio Sci Notes2017
28886055Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products.PLoS One2017
28877781Letters to the Editor.Allergy Asthma Proc2017
28760498Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.Semin Immunol2017
28052795Enhancing sublingual immunotherapy by systemic or local factors: A role for vitamin D and lingual tonsil?Allergy Asthma Proc2017
27731323The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation.Mucosal Immunol2017
27965111Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy.J Allergy Clin Immunol2017
26813047Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America.Expert Rev Clin Immunol2016
26485347Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.Allergy2016
26652799Allergen extracts for immunotherapy: to mix or not to mix?Expert Rev Clin Pharmacol2016
26617233Biomarkers for Allergen Immunotherapy: A "Panoromic" View.Immunol Allergy Clin North Am2016
26522402Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy.J Allergy Clin Immunol2016
27534655Proteomics for Allergy: from Proteins to the Patients.Curr Allergy Asthma Rep2016
27140409Allergen immunotherapy for birch pollen-allergic patients: recent advances.Immunotherapy2016
27129273Structural and Functional Characterization of the Major Allergen Amb a 11 from Short Ragweed Pollen.J Biol Chem2016
27018782Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1.Allergy2016
26949057Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjects.J Allergy Clin Immunol2016
25744907Specific IgE recognition of pollen allergens from subtropic grasses in patients from the subtropics.Ann Allergy Asthma Immunol2015
26657494Will Allergen Fusion Bring New Energy to Immunotherapy?Int Arch Allergy Immunol2015
26383916New insights into ragweed pollen allergens.Curr Allergy Asthma Rep2015
26317427Identification of Novel Short Ragweed Pollen Allergens Using Combined Transcriptomic and Immunoproteomic Approaches.PLoS One2015
26143936Focusing the mechanism of action to dissect the different treatments of respiratory allergy.Expert Rev Clin Immunol2015
25846209Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients.Allergy2015
25918982Der p1 and Der p2-Specific T Cells Display a Th2, Th17, and Th2/Th17 Phenotype in Atopic Dermatitis.J Invest Dermatol2015
  • 1 - 50 of 185

Recommended Authors

Beatrice Dyring-Andersen
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year 2011
Number of shared co-authors 0
Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
Jacob D Eccles
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 1
Kirstin Jansen
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich
Career Start Year 2008
Number of shared co-authors 0
Matthew C Altman
University of Washington School of Medicine, Seattle Benaroya Research Institute
Career Start Year 2007
Number of shared co-authors 2
Kristina M Harris
University of California san francisco
Career Start Year 2006
Number of shared co-authors 3
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
Rachana Agrawal
University of Virginia School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Florence A Castelli
Universite Paris Saclay
Career Start Year 2002
Number of shared co-authors 1
Bjoern Peters
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 2
Michelle A Gill
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 0
Joshua D Milner
Columbia University
Career Start Year 1999
Number of shared co-authors 1
Jane H Buckner
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1995
Number of shared co-authors 2
Manish J Butte
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Judith A Woodfolk
University of Virginia School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Lisa M Wheatley
National Institutes of Health
Career Start Year 1991
Number of shared co-authors 2
Jonathan A Bernstein
University of Cincinnati College of Medicine, and Bernstein Clinical Research Center
Career Start Year 1990
Number of shared co-authors 0
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 0
Gurjit K Khurana Hershey
Cincinnati Children's Hospital Medical Center
Career Start Year 1989
Number of shared co-authors 0
Clare Baecher-Allan
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1988
Number of shared co-authors 1
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year 1984
Number of shared co-authors 2
Lisa J Workman
University of Virginia
Career Start Year 1984
Number of shared co-authors 1
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Rebecca S Gruchalla
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 0
Thomas E Fehniger
Biomedical Center, Lund University
Career Start Year 1979
Number of shared co-authors 0
Carl A K Borrebaeck
Lund University
Career Start Year 1977
Number of shared co-authors 0
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
Thomas A E Platts-Mills
University of Virginia
Career Start Year 1974
Number of shared co-authors 1
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 1

Collaborators

Laurence Van Overtvelt
Universite Libre de Bruxelles
Co-authored papers 28
Erik Wambre
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 9
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Co-authored papers 7
David J McConkey
Johns Hopkins School of Medicine
Co-authored papers 4
Jeremy Mason
European Molecular Biology Laboratory - European Bioinformatics Institute
Co-authored papers 3
Manu Shankar-Hari
King's College London
Co-authored papers 3
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 2
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 2
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 2
Julie A McMurry
University of Colorado - Anschutz Medical Campus
Co-authored papers 1
Leonard Moise
EpiVax Inc.
Co-authored papers 1
Julia Chamot-Rooke
Institut Pasteur, Universite Paris Cite, CNRS UAR4
Co-authored papers 1
David Enard
University of Arizona
Co-authored papers 1
Anne S De Groot
University of Georgia
Co-authored papers 1
William D Martin
EpiVax Inc.
Co-authored papers 1
Fran??ois Fenaille
Universite Paris-Saclay
Co-authored papers 1
David W Scott
University of British Columbia
Co-authored papers 1
Peter S Linsley
8Benaroya Research Institute
Co-authored papers 1
Kenneth C Anderson
Dana Farber Cancer Institute
Co-authored papers 1
Renaud Vincentelli
CNRS, Aix-Marseille Universite
Co-authored papers 1
Release 1.2